1
/
of
1
ELK Biotechnology
SKU:ELK5266
Human FGF13(Fibroblast Growth Factor 13) ELISA Kit
Human FGF13(Fibroblast Growth Factor 13) ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Human FGF13(Fibroblast Growth Factor 13) ELISA Kit
Overview
| Product name: | Human FGF13(Fibroblast Growth Factor 13) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | FHF2; Fibroblast Growth Factor Homologous Factor 2 |
| Assay Type: | Sandwich |
| Sensitivity: | 13.1 pg/mL |
| Standard: | 500 pg/mL |
| Range: | 7.82-500 pg/mL |
| Sample Type: | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Length: | 3.5h |
| Research Area: | Cytokine; |
| Test principle: | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human FGF13. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human FGF13. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human FGF13, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human FGF13 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 500.00 | 2.126 | 2.044 |
| 250.00 | 1.562 | 1.480 |
| 125.00 | 1.114 | 1.032 |
| 62.50 | 0.863 | 0.781 |
| 31.25 | 0.651 | 0.569 |
| 15.63 | 0.381 | 0.299 |
| 7.82 | 0.174 | 0.092 |
| 0.00 | 0.082 | 0.000 |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant FGF13 and the recovery rates were calculated by comparing the measured value to the expected amount of FGF13 in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 81-95% | 88% |
| EDTA plasma(n=5) | 77-95% | 86% |
| Heparin plasma(n=5) | 83-97% | 90% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of FGF13 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 85-96% | 87-101% | 89-97% | 85-94% |
| EDTA plasma(n=5) | 81-94% | 78-90% | 83-95% | 86-97% |
| Heparin plasma(n=5) | 80-94% | 90-99% | 87-103% | 83-96% |
Share
